approved prescription drug products · 8/13/1980  · supplement i .. 1-3 i! with cumula. tive...

18
I .. SUPPLEMENT 1-3 I! WITH CUMULA. TIVE INDEX 980 EDITION APPROVED PRESCRIPTION DRUG PRODUCTS WITH THERAPEUTIC EQUIVALENCE EV ALUA nONS u.s. DEPARTMENT OF HEALTH AND HUMAN SERVICES PUOLIC HEALTH SErWICE FOOD AND Dfl,UG ADMINISTMTION OUfl,EAU OF Dfl,UGS

Upload: others

Post on 22-Oct-2020

3 views

Category:

Documents


0 download

TRANSCRIPT

  • I ..

    SUPPLEMENT 1-3 I!

    WITH CUMULA. TIVE INDEX ~ 980 EDITION

    APPROVED PRESCRIPTION DRUG PRODUCTS

    WITH THERAPEUTIC EQUIVALENCE

    EV ALUA nONS

    u.s. DEPARTMENT OF HEALTH AND HUMAN SERVICES PUOLIC HEALTH SErWICE

    FOOD AND Dfl,UG ADMINISTMTION OUfl,EAU OF Dfl,UGS

  • --- - ---------------

  • F'CDD AND DRU:; ADMINISTRATION APPROVED PREOCRIPTION DRU:; PRODOCTS

    WITH 'IHERAPEUTIC EQUIVAI.EN:E EVALUATIONS

    SUPPLEMENT

    I. PRE:rnCE

    This suwlement is one of a series of periodic up:3ates to the list of Approved Prescription Drug Products with Therapeutic Equivalence Evaluations (the List) to cover revisions interim to the annual publication of the List in its entirety. This suwlement contains updates to the Drug Product List and Appendix portions of the List, as VJell as cumulative indices for both.

    1. Drug Product List

    The Drug Product List reV1Slons are intended to be pen and ink changes to the annual publication of the List rather than page replacements or cut-and-paste changes. The changes in this supplement contain revisions made since the last publication or previous supplement.

    In general, information in this listing follows the format of the Drug Product List. Information to be deleted from the Drug Product List is indicated by an overstruck print. Information to be added to the Drug Product List is indicated by the symbol>~> to the left of the line on which new information exists. Any line containing neither the overstruck print nor>~> is necessary to provide the context information needed to assist in locating the proper place in the Drug Product List for the revision.

    A change of information concerning a given drug product covers only enough context information to facilitate making the change. The change itself is indicated by deleting the old information, directly followed by adding the nEW information.

    The addition of a therapeutic equivalence code indicates that the drug product has beccme multisource~ the deletion of a therapeutic equivalence code indicates that the drug product has become single source. A change in the therapeutic equivalence code is indicated by a delete, immediately followed by an add on the line below indicated by an > _{\DD >

  • -2-

    2. Appendix--Prescription Drug Products Deemed Approved Pendjng Resolution of Safety or Effectiveness Issues

    The listing for the Appendix contains only drug products which are the subject of additions, removals, or classification changes within the Appendix. These revisions are indicated in the same manner as addition and removal of drug products for the Drug Product List.

    3. Cumulative Indices

    Each supplement is accompanied by a cumulative index. These are intended to provide a ready record of all revisions occurring from one annual List publication to the next. Each index will be alphabetical, the Drug Product List by ingredient and the Appendix by trade name.

    II. SPECIAL NOTES

    1. The 2nd Edition of this publication is scheduled to be available as a new subscription from the Government Printing Office (GPO) in October, 1981. It will contain data current through July, 1981. The first supplement to that edition will contain updates covering both August and September, 1981, and is intended to be distributed by GPO with the publication. All supplements to the 2nd Edition will be provided as part of the base subscription price.

    2. A subscription form has been provided at the end of this supplement to assist in extending the subscription to this publication through the 2nd Edition (1981 publication).

    II

    a..:" Wi

  • • ACETAMINOPHEN; CODEINE PHOSPHATE

    ELIXIR; ORA L ACETAM!HOrHEH WI CODE!NE

    • APPROVEO PRESCRIPTION DRUG PRODUCTS

    DRUG PRODUCT LIST SUPPLEMENT NUMBER 13

    >~> ATENOLOL

    TABLET; ORAL THIORMIN I

    ,·-_"""?",~,,q;B:~

    1

    >~> AA PHARM ASSOCIATES lZOMG/SHL;12HG/SHL

    >~>

    >i!2!L>

    >~> STUART PHAR~S/ICI I

    SOMG * IOOMG

    >~>

    ACETIC ACID, GLACIAL

    SOLUTION; OTIC ACETASOL

    >-AillL> AT NATL PHARM MFG/BARRE 27.

    > -AillL>

    > ADQ....>

    AMINO ACIDS

    INJECTABLE; INJECTION

    ! /#r!#.Yrl/li / AMH~OSYN-RF 5.2%

    ABBOTT LABS ! #/ 5.2%

    AMINOPHYLLINE

    INJECTABLE; INJECTION AHltmrIlYlL!NE

    > .-M1!L > AI' L YPHO-tIED 25MG/HL

    ASPIRIN; BUTALBITAL; CAFFEINE; PHENACETIN

    TABLET; ORAL BUTAL~!TAl WI APC

    >~> AS LEDERLE LABS/AM CYAN ZOOMG;SOMG;40MG;130MG

    ATROPINE SULFATE; IOIPHENOXYLATE HYOROCHLORIDE

    TABLET; ORAL DIFHEliO)(YLATEIHCL WI ATROl'!"'E SULFATE

    >~> AA PREMO PHARM I LABS 25 U~H;2.5MG

    CALCIUM CHLORIDE; I DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUMILACTATE

    INJECTABLE; INJECTION DEXTROSE 5Y. !~ LACTATED RINGER'S IH PLASTIC COHTA!NER

    >-AillL> AI' CUTTER LABSI 2nHG/IOOHL;59~~/10Ct!L;!CHG/IOOHL; > -ARJL> AI'

    CH LORTHA LIDONE i

    >~> AS >-AillL> AS

    I

    TABLET; ORAL I CHUlRTHAL!DOHE

    I

    CHElSEA LABS !

    DAHBURYPHAr'ACAL

    CORTISONE ACETATEI

    > -AillL>

    i INJECTABLE; INJECTION

    I CORTISONE ACE~ATE

    !p,!)'( '##rl#¥,J,fNlt:f,/ LE~'t'ON I

    6 COHGn0011L; 31 O:'I~/I0I)ML

    25MG t! SaM~ ?.-?HG t! 50.H~

  • APPROVED PRESCRIPTION DRUG PRODUCTS DRUG PRODUCT LIST

    SUPPLEMENT NUMBER 13

    !;"YP'30HEPTADINE HYDROCHLQRIDE FUROSEMIDE

    >2Q!L> AA

    TABLET; ORAL CYr-~OHEPTAOrHF. Hel

    PREtlO F'HARM LABS 4MGI

    I

    DIHYDROERGOCORNINE MESYLATE; DJHYDROERGOCRISTINE MESYLATE;

    AA

    I

    DIHYDROEPGOCRYPTINE MESYLATE

    TABLET; SUBLINGUAL DI!iYN~OET!50T"XINE METtI.'~NES~~lFOt{'!lTE

    -_. !U-/w;t,Tm 'MrUU.J'udH 'f! KV PHAPMCEUTICAL ERGO Lorn HESYLATES

    BARR LABS 167 lSH;167 USH;167 UGH * 333 UGH; 333 1l'!:;H;;~

    TABLET; ORAL lAsrx

    > ADD > AS HOECHST-ROUSSEL >-ARJL> FURO!iEH!OE

    >~> AS MYLAN PH ARMS

    GLYCOPYRROlATE

    TABLET; ORAL GLYCOPYRROlATE

    >~> AA DANBURY PHARNACAL

    2

    20MG * 40MG

    20HG * 40NG

    1HG * 2MG >2Q!L> AA >2Q!L> At!.

    >~..P_> AA KV PHARMACEUTICAL 167 iUG'!; 167 UGH;16 7 UGN HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE; RESERPINE

    ERYTHROMYCIN ETHYLSUCCINATE I

    SUSPENSION; OR;\L

    AS

    >2Q!L> AS

    E~YTli~t'HYCIN ETHYlSl'CCIHATE

    NATL PHARM MFG/BARRE Eg ZOO!"lG BASE/SNL * Eg ~OOHG BASE/SML

    ESTROGENS, CONJUGATED

    >2Q!L> BS

    --

    TABLET; ORAL CONJUGATED ESTROGENS

    CHELSEA LABS 6251UGN * 1.25NG * 2.5NG

    e

    TABLET; ORAL >~> HYDROCHLOROTHIAZIDE/HYDRALAZINE HCL/RESERPINE >~> BP DANBURY PHARMACAL

    HYDROCHLOROTHIAZIDE

    >~> AS AS

    >~>

    >~> AS

    TABLET; ORAL HYDROCHlOROTHIAZrDE

    PUREPAC PHARM REID-PROVIDENT LABS

    ZInE

    REID-PROVIDENT LABS

    HYDROCORTISONE

    OINTMENT; TOPICAL HY!lROCORT:!SOHE

    25MG;15MGilOO UGN

    2!'~IG * SONG 2!'HG '!,'id~,j/

    SOMG

    AT SHAFFER-DAVIS LABS o.S7.',J,'jjj, >~> AT THAMES PHARMACAL 17.

    fit

  • • HYDROCORTISONE ACETATE

    INJECTABLE; INJECTION HYDROCORTISONE ACETATE

    !P'!~, '?#f#,r!,E~jj#t:j,/ >~> LEMMON

    HYDROXYZINE HYDROCHLORIDE

    INJECTABLE; INJECTION HYOP-OXYZINE HCL

    > ...AQJL> AP L YPHO-tlED >-AQ~> AP NATCON CHEMICAL

    HYDROXYZINE PAMOATE

    CAPSULE; ORAL >~> HYDROXYZINE PAMOATE

    > _ADD > AB BOLAR PHAR~l

    >...AQ~> AS

    >~> Al3

    >~> AS

    V:r-,"TA~!L

    PFIZER LABS

    >~~> IODOXAM~TE MEGLUMINE

    > ~> INJECTABLE; II'-IJECTION >~> CHOLOVUE

    • APPROVED PRESCRIPTION DRUG PRODUCTS

    DRUG PRODUCT LIST SUPPLEMEtH NUMBER 13

    2SMG/HL 'IE S()HGlML 2SHG/HL 'IE SOMG/HL

    Eq 25HG HCL 'IE Eg SONG HCL 'IE Eq IOOHG HCL

    Eq 2SMG HCL 'IE Eg SOMG HCL 'IE Eg lO0!1G HCL

    I LEVOPROPOXYPHENE NAPSYLATE

    . I

    SUSPENSION; ORAL

    NOVRAD I

    / '.1 '.I ".I "PI F,Lf, )'f,Lj-, I. >...AQ~> ELI LILLY I, INDSTRS/PR

    LIDOCAINE

    OINTMENT; TOPICAL

    LIDOCAINE I >~> AT THAMES PH~RMACAL

    METHOXSALEN

    >...MUL> CAPSULE; ORAL >~> OXSORALEN

    I >...MUL> ELDER PHArS

    I LOTION; TOPICAL

    °/;J~t,~~:it##/ >~> ELDER PHARMS

    METHYLDOPA

    I

    > ADD> SUSPENSION; ORAL >~> ALDCMET I

    > ....A.QIL> ER SQUIBB AND SONS 9.9% * 40.3% >~> MERCK SH/'r & DOHME

    >~>

    LEVOPROPOXYPHENE NAPSYLATE

    CAPSULE; ORAL NOvrlAD

    1.1(1I1J'U/ I F, f, j-fj-, , ELI LILLY INDSTRS/PR > ADD >

    PHENDIMETRAZINEITARTRATE

    TABLET; ""AL l METRA

    /p)/, '#HJ(' p!Vl-/-p/! ONEAL JONES&FELDMAN

    I

    3

    S~

    10MG

    250MG/5ML

  • POTASSIUM CHLOPIDE

    ItlJECTABLE; ItlJECTIOH F'OTAS~IUM Cl"L()~!DE

    I

    I

    I >...AQJL> AP LEM~10N 211EQ/ML

    PREDNJSOLONE ACETATE

    INJECTABLE; INJECTION PREONISOLONE ACETATE

    /p'!r~, '/~!Pl~lct.JHl/#1 > -A.!llL > LEtl~10N

    PROCAINAHIDE HYDROCHLORIDE

    >..AQJL> BC >~>

    >...AQJL> Be

    TABLET, CONTROLLED RELEASE; ORAL

    PROCAt~ I PARKE-DAVIS/W-L SOOt1G

    PROI~ESTn-SR I ER SQUIBB AND SONS SOONG

    PROCAINE HYDROCHLORIDE

    >...AQJL>

    > ADD>

    -

    INJECTABLE; INJECTION PRO'CA!HF. HCL

    / p,!~, 'N#iV#,Jf;f.#//,J LEHMON

    QUINIDINE SULFATE

    TABLET; ORAL QUIH![INE SULrATE

    /##/-/-,'pp,JN REXALL

    APPROVED PRESCRIPTION DRUG PRODUCTS DRUG PRODUCT LIST

    SUPPLEMENT NUMBER 13

    >..AQJL>

    >..AQJL>

    >..AQJL>

    SULF .

  • TRIA~ICINOLONE ACETONIOE

    CREAM; TOPICAL TR:tAMCIHr.lLOHE AI'~IHOHID E

    /'~#fI#,!~,i.;J#,'/-/#/ > ADO> THAtIES PHARMACAL

    TRIAMCINOLONE OIACETATE

    INJECTABLE; INJECTION TRIAMcnmLONE OIACETATE

    /~A{ 'f~i#J#pfj#/-,S/ > -A!2!L> LEtIMON

    TRISULFAPYRIMIDINES

    SUSPENSION; ORAL SUL~ALO:tO

    / p,J/, ',#N#pJV../-/-p// >-A!2!L> ONEAL JONES&FELOMAN

    > .-.AmL> VERAPAMIL HYDROCHLORIDE

    >-A!2!L> INJECTABLE; INJECTION >-A!2!L> ISOPTIN >-A!2!L> KNOll PHARM 2.5MG/HL

    .... -~'''.,

    • APPROVED PRESCRIPTION DRUG PRODUCTS DRUG PRODUCT LIST

    SUPPLEMENT NUMBER 13

    ry,"\I1::';f,?;f\~~~~$l~~~!~~~1'F e" ,""',',,' 5

  • e

    APPROVED PRESCRIPTION DRUG PRODUCTS DRUG PRODUCT LIST

    CUMULATIVE INDEX

    INGREDIENT( S) I

    SUPPLEMENT: 1 2

    ACETAMINOPHEN; CODEINE PHOSPHATE X X ACETIC ACID, GLACIAL

    I

    X ACETYLCHOLINE CHLORIDE ALBUTEROL

    I AMANTADINE HYDROCHLORIDE

    AMINO ACIDS AMINOGLUTETHIMIDE AMINOPHYLLINE X AMITRIPTYLINE HYDROCHLORIDE X AtfOXAPINE X

    AMOXICILLIN TRIHYDRATE I X AMPICILLIN/AMPICILLIN TRIHYDRATE ASPIRIN; BUTALBITAL; CAFFEINE; PHENACETIN ASPIRIN; CAFFEINE; PHENACETIN; PROPOXYPHENE HYDROCHLORIDE ATENOLOL

    I ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE X BACAMPICILLIN HYDROCHLORIDE BACI1?d.CIN BETHANECHOL CHLORIDE BETHANIDINE SULFATE

    BISHYDROXYCOUMARIN BROMPHENIRAMINE MALEATE BUTABARBITAL SODIUr1 CAFFEINE; ERGOTAMINE TARTRATE CALCIFEDIOL X

    I CALCIUM CHLORIDE; DEXTROSE; HA~NESIUH CHLORIDE; POTASSIUM

    CHLORIDE; SODIUM ACETATE; SOO]Utl CHLORIDE CALCIUM CHLORIDE; DEXTROSE; MA~NESIUtl CHLORIDE; POTASSIUM

    CHLORIDE; SODIUM ACETATE; SOD]Utf CHLORIDE; SODIUM CITRATE CALCIUM CHLORIDE; DEXTROSE; MA9NESIUI1 CHLORIDE HEXAHYDRATE;

    SODIUM ACETATE; SODIUr1 CHLORI~E X CA LC IUM CH LOR ID E; 0 E XTR 0 5 E; POliASS IUM CH LOR ID E; SOD IUM

    CHLORIDE; SODIUM LACTATE

    I CAPTOPRIL

    CARBINOXAtlINE MALEATE CEFADROXI L tlOt-1OHYDRATE CEPHALORIDINE CHLORAtIPHENICOL; DESOXYRIBONUCL EASE; FIBRINOLYSIN CHLORAMPHENICOL; HYDROCORTISONE ACETATE X

    CHLORDIAZEPOXIDE HYDROCHLORIDE I CHLOROQUINE PHOSPHATE X CHLOROTHIAZIDE CHLORPHENIRAMINE MALEATE CH LORPRDt1AZINE HYDROCH LORIDE X

    e

    6

    3 4 5 6 7 B 9 10 11 12 13

    X X X X

    X X

    X -

    X X X X

    X X X X

    X X X

    X X

    X X X X X

    X X

    X

    X X X X

    X X X

    t-- --- -".-

    X

    X

    X X

    f--- - --X

    X X X

    X

    f-- -X

    X X X X X X X X X X

    fa

  • • INGREDIE

    CHLORPRO CHLORTHA CHnlOTRY CLORAZEP CLORAlEP

    CORTI SON CORTISOlI CROTAtHT CYCLACIL CYCLOTHI

    CYPROHEP DACARBAZ DANAlOL DEXAMETH DEXAI1ETH

    DEXAtIETH DEXCHLOR DEXTROAtl DEXTROSE DEXTROSE

    DEXTROSE ACETATE

    DEXTROSE ACETATE

    DEXTROSE SODIUM

    DEXTROSE DEXTROSE

    DIATRIlO DIATRIlO DIAZEPAM DICU~14RO

    DIETHYLS

    DIHYDROE DIHYDRO

    DUIENHYD DINOPROS DINOPROS DIPHEtJAD

    • APPROVED PRESCRIPTION DRUG PRODUCTS DRUG PRODUCT LIST

    CUMULATIVE INDEX

    NTCS) SUPPLEMENT: 1 2

    PMlIDE LIDONE PSW ATE DIPOTASSIUM X ATE tlONOPOTASSIUM

    E ACETATE E ACETATE; NEOMYCIN SULFATE X ON LIN AZIDE

    TADINE HYDROCHLORIDE INE

    X ASONE ASONE SODIUM PHOSPHATE X

    ASmlE SOD IUM PHOSPHATE; NEmlYCIN SULFATE X PHENIRAMINE MALEATE PHETAMINE SULFATE X

    X ; LIDOCAINE HYDROCHLORIDE

    ; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ; SODIUM CHLORIDE ; tIAGt'ESIU~l CHLORIDE; POTASSIUM CHLORIDE; SODIUM ; S09IUM CHLORIDE; SODIUM GLUCONATE X ; POTASSIUtl CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; ACETATE; SODIUM CHLORIDE ; POTASSIUM CHLORIDE i SODIUM CHLORIDE - IN PLASTIC X i SODIUM CHLORIDE

    -- -ATE MEGLUtlINEi DIATRIlOATE SODIUM "TE SODIUtl

    L TILBESTROL

    RGOCORNINE MESYLATE; DIHYDROERGOCRISTINE MESYLATE; ERGOCRYPTINE MESYLATE RINATE TONE TONE(PROSTAGLANDIN E-2) IOtJE X ------

    DIPHENHY DrSULFIR DOPAtHNE DOXEPIN DOXYCYCL

    DRAMINE HYDROCHLORIDE t.M

    HYDROCHLORIDE HYDROCHLORIDE INE HYCLATE

    • 7 3 4 5 6 7 8 9 10 11 12 13

    X X X X X X X X X

    X

    X

    X

    X X

    X

    X X X X X '. X

    X

    I

    X X X

    X X

    X X X

    X

    X

    X

    X

    X X

    X X

    X

    X X X X X X

    X X

    X X X

    X X X

    X

  • APPROVED PRESCRIPTION DRUG PRODUCTS DRUG PRODUCT LIST

    CUMULATIVE INDEX

    INGREDIENT( S) I

    SUPPLEMENT: 1 I 2 I 3 I 4 I 5 I 6 I 7 I 8 I 9 110 III 112 1 13

    EPINEPHRINE; LIDOCAINE HYDROCHLORIDE ERYTHRmlYCIN i ERYTHROMYCIN ETHYLSUCCINATE I ESTRADIOL VALERATE I ESTRADIOL VALERATE; TESTOSTERONE ENANTHATE

    ESTROGENS, CONJUGATED ESTROGENS, ESTERIFIED FENOPROFEN CALCIUM FENOPROFEN CALCIUM DIHYDRATE FLUORESCEIN SODIUM

    X I I X X I I X

    X I ) X I X X

    X

    X I I X I X X

    X X I X

    X

    I

    'I

    ------- ' f--F LUOXnlESTERONE I FOLIC ACID I

    X I X

    FOLLICLE-STIMULATING HORMONE; LUJENIZING HORMONE FUROSEMIDE I GENTAMICIN SULFATE

    GLUTETHIMIDE I GLYCOPYRROLATE I GRISEOFULVIN, ULTRAMICROCRYSTALLINE X

    X

    X X

    X I X

    X

    X X

    X

    X

    HEPARIN SODIUM HEXACHLOROPHENE HEXOCYCLIUM METHYLSULFATE HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE

    X

    X I I X I ~ I X I I ~ I I X

    HALOTHAtlE 1 HEPARIN CALCIU~1--------------T-I--------------+--t---+--+---t--+--+---+-+---'-II---+--+

    I HYDROCHLOROTHIAZIDE; RESERPINE

    I

    RESERPINE I SPIRONOLACTONE

    HYDROCHLOROTHIAZIDE; HYDROCHLOROTHIAZIDE; HYDROCORTISONE HYDROCORTISONE ACETATE

    I HYDROCORTISot~E; NEOMYCIN SULFATE; POLYMYXIN B SULFATE

    I

    HYDROCORTISONE ACETATE; NEOMYCINISULFATE HYDROCORTISONE ACETATE; OXYTETRACYCLINE HYDROCHLORIDE HYDROCORTISONE SODIUM SUCCINATE I HYDROXOCOBALAMIN HYDROXYZINE HYDROCHLORIDE I

    HYDROXYZINE PAMOATE IBUPROFEN IMIPRAMINE HYDROCHLORIDE IODOXAMATE MEGLUMINE IOTHALAftoHE SODIU~l, 1-125

    x

    X X

    x x I ' I X

    X I I X I I X

    X X

    xl Ixi X IXIXIX X

    X I X I I I X xl X X ~IXIXIX

    X x

    X I X x X

    X ---------------------T-----------------------------r~--_r--f--_r--r--+---+--~--+-~---~

    IRON DEXTRAN COMPLEX ISOETHARINE HYDROCHLORIDE

    e ie X X I X x

    8

    e

  • • .' APPROVED PRESCRIPTION DRUG PRODUCTS -9 DRUG PRODUCT LIST CU~IULATIVE INDEX

    INGREDIENT! S) SUPPLEMENT: 1 2 3 4 5 I 6 7 8 I 9 10 11 12 13

    ISONIAZID X X I X X ISDSORBIDE X ISOSULFAN BLUE X KETOCONAlOLE X LEVOPROPOXYPHENE NAPSYLATE X

    LIDOCAINE X LIDOCAINE HYDROCHLORIDE X X X LITHIUM CARBONATE X X X LITHIUM CITRATE X X X LORAZEPAM X

    .-MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM

    I CHLORIDE; SODIUM GLUCONATE X N.o.NNITOL X MANNITOL; SORBITOL X MAPROTILINE HYDROCHLORIDE X ~IAZH1DOL X

    I -- -NECLIZINE HYDROCHLORIDE X NECLOCYCLINE SULFOSALICYLATE X MEPERIDINE HYDROCHLORIDE X X NEFROBA~IATE X

    I

    X X METAPROTERENOL SULFATE X

    -METHADONE HYDROCHLORIDE X NETHAQUALOI~E X NETHDILAZINE HYDROCHLORIDE X METHOXSALEN X METHYlDOPA X

    .-

    METHYLPREDNISOLONE X METHYLPREDNISOLONE; NEOMYCIN SULFATE X METHYLPREDNISOLONE ACETATE X METHYLFREDNISOLONE SODIUM SUCCINATE X METHYLTESTOSTERONE X X X

    METOCLOPRMIIDE HYDROCHLORIDE X ~IETO LAZONE X METRONIDAZOLE HYDROCHLORIDE X MICONAZOLE NITRATE X MOLINDONE HYDROCHLORIDE X

    NADOLOL X NAPROXEN SODIU11 X NEOMYCIN SULFATE; PREDNISOLONE X X NEOMYCIN SULFATE; PREDNISOLONE ACETATE X NEmlYCIN SULFATE; PREDNISOLONE SODIUt1 PHOSPHATE X

    I

    -f---NEOSTIGMINE BROMIDE X

  • INGREDIENT(S)

    NITROFURAZONE NORETHINDRONE NOVOBIOCIN CALCIUM NOVOBIOCIN SODIUM ORPHENADRINE CITRATE

    OXACILLIN SODIUM NONOHYDRATE OXYTOCIN OXYTOCIN CITRATE PENICILLIN G POTASSIUM PENICILLIN G PROCAINE

    PENICILLIN G SODIUM PENICILLIN V POTASSIUM PENTOBARBITAL SODIUM PHENDIt1ETRAZINE TARTRATE PHENTERMINE HYDROCHLORIDE

    PHENYTOIN SODIUM POTASSIUt1 CHLORIDE PRAZEPAM PREDNISOLONE PREDNISOLONE ACETATE

    I

    I

    !

    I

    I

    I

    I I

    I

    APPROVED PRESCRIPTION DRUG PRODUCTS DRUG PRODUCT LIST CU~lULATIVE IlmEX

    SUPPLEMENT: 1 2

    X X

    X X

    X

    X

    X X X

    PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM X PREDNISOLONE SODIUM PHOSPHATE i PREDNIsmlE PROCAINAMIDE HYDROCHLORIDE I PROCAINE HYDROCHLORIDE

    I

    PROMETHAZINE HYDROCHLORIDE PROPIOLACTONE PROPOXYPHENE HYDROCHLORIDE PSEUDOEPHEDRINE HYDROCHLORIDE

    I PYRIDOXINE HYDROCHLORIDE X

    QUINIDINE SULFATE RAUWOLFIA SERPENTINA RESERPINE RESERPINE; TRICHLORMETHIAZIDE X RITOORINE HYDROCHLORIDE X

    ARALASIN ACETATE COPOLAmNE COPOLAMINE HYOROBROMIDE ECOBARBITAL SODIUM ECRETIN

    ODIUM AMINOSALICYLATE X ODIUM CHLORIDE

    e e

    3 4

    X

    X X

    X

    X X

    X

    X X

    10

    5 6 7 8 9 110 11 12 13

    X X X

    X X

    X

    X

    X X

    X X X X

    X X X I---

    X X X

    X X

    X

    X X X X X

    j--+- -f--X X

    X X X

    X X

    -I---j--- ---X X X

    X

    X -- j---

    X

    X X X X

    -f---- -- f-- --f---

    X

    e

  • • APPROVED PRESCRIPTION DRUG PRODUCTS • l~ DRUG PRODUCT LIST CUMULATIVE INDEX

    INGREDIENT! S) SUPPLEMENT: 1 2 3 4 5 6 7 '6 9 10 11 12 13

    SOYBEAN OIL X SPIRONOLACTONE X X X SULF M1ETHIZOLE X SULFAMETHOXAZOLE X X SULFAMETHOXAZOLE; TRItlETHOPRIM X X

    SULFASALAZINE X X X X SULFISOXAZOLE X X X X X X TECHNETIUt1, TC-99M, ETIDRONATE KIT X TECHNETIUM, TC-99M, MEDRONATE KIT X X TECHNETIUM, TC-99M, OXIDRONATE KIT X

    TECHNETIUM, TC-991', PENTETATE KIT X TECHNETIUM, TC-99tt, PYROPHOSPHATE KIT X TEI'lAlEPp,M X TESTOSTERONE CYPIONATE X X TESTOSTEROIIE ENMlTHATE X X -----TETRACYCLINE HYDROCHLORIDE X THEOPHYLLINE X X X TOLBUTAmDE X X TRIAtlCINOLOtlE ACETONIDE X X TRIAtlCINOLOflE DIACETATE X X

    TRICHLORMETHIAZIDE X X TRISULFAPYRIMIDINES X X X VERAPAMIL HYDROCHLORIDE X VITAMIN A X WATER, FOR INJECTION X

    XYLOSE. O- X ZmlEPIRAC SODIUM X

    :~~'h=

  • : .... ~::i:.

    PRESCRIPTION DRUG PRODUCTS DEEMED APPROVED PENDING RESOLUTION OF SAFETY OR EFFECTIVENESS ISSUES

    SUPPLEMENT NU~lBER 13

    CURRENT STATUS ~ INEFFECTIVE

    OXSORALEN INol-,/~,'I/-p#/ > ADD > ELDER PHARMS

    - /,61;1r4~~

  • • • PRESCRIPTION DRUG PRODUCTS DEEMED APPROVED -13 PENDING RESOLUTION OF SAFETY OR EFFECTIVENESS ISSUES CUHULATIVE INDEX

    TRADE NAME SUPPLEMENT: 1 2 3 4 5 6 7 8 9 10 11 12 13

    ACHROMYCIN X BACITRACIN; NEOMYCIN; POLYMYXIN; HYDROCORTISONE ACETATE X BARBIDONNA X BARBIDONNA NO.2 X BENTYL WI PHENOBARBITAL X

    BIOlYHE X I BUTIBEL X

    CANTIL WI PHENOBARBITAL X I CHLOROMYCETIN HYDROCORTISONE X CLISTl,~ EXPECTORANT X

    ---

    COR-OTICIN X CORTISPORIN X DACTIL X X DACTIL AND PHENOBARBITAL X X DARICON PB X

    --DICYCLOHINE HCL X DIPYRIDAtlOLE X X DONNATAL X DYSPAS X FLORINEF-S X

    ---ISOSORBIDE DINITRATE

    I

    X LEVSIN PB X LEVSIN WI PHENOBARBITAL X LIBRAX X MEPROBA.t!ATE WI TRIDIHEXETHYL CHLORIDE X X

    METI-DERM WI NEOMYCIN X I METIHYD X MILPATH-200 X MILPATH-400 X NEO-ARISTOCORT ACETON!DE X

    I

    I

    e-----NEO-DELTA-CORTEF X NEO-DELTEF X NEO-MEDROL X NEOQUESS X X NEOSONE X

    NITROGLYCERIN X X X NYSTATIN, NEOMYCIN SULFATE, GRAMICIDIN, TRIAl1CINOLONE ACETONIDE X OPfiTHOCORT X ORTHOXINE X

    I OXSORALEN X

    PARAFON FORTE X I PATHIBAMATE-200 X

    -- ~rU&

  • L

    TRA DE NAtlE

    PAT PAT PHE PIT POL

    PRE PRO PRO ROB ROB

    SPA SUL T.C T.C TER

    TRA

    '1IBAm,TE-400 ,ILON WI PHENOBARBITAL ~OBARBITAL & BELLADONNA DCIN CITRATE Y-PRED

    DMYCIN-P -BANT/UNE WI OARTAL -BANTHHlE WI PHENOBARBITAL INUL-PH INUL-PH FORTE

    LIX FATHALIDINE .M. 200 .M. 400 RA-CORTRIL

    L GRADUMET

    PRESCRIPTION DRUG PRODUCTS DEEMED APPROVED PENDING RESOLUTION OF SAFETY OR EFFECTIVENESS ISSUES

    CUMULATIVE INDEX

    SUPPLEMENT: 1 2 3 4

    X

    X

    X

    X

    v

    14

    5 6 7 8 9 10 11 12 13

    X X

    X X

    X X , X X X X

    X

    X X

    X I

    J